Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Robotic-Enabled Microsurgical Intervention for Neurodegenerative Disease

NCT: NCT07178210 · RECRUITING

NCT IDNCT07178210
StatusRECRUITING
Start Date2026-03-31
Completion2027-08-31

Brief Summary

The objective of this investigational device exemption (IDE) study is to evaluate the safety and feasibility of using the Symani System and microsurgical techniques in the deep cervical lymph node (dCLN) region in the setting of mild to moderate Alzheimer's disease and lymphatic abnormalities.

Frequently Asked Questions

What is Robotic-Enabled Microsurgical Intervention for Neurodegenerative Disease?

Robotic-Enabled Microsurgical Intervention for Neurodegenerative Disease is a clinical trial registered under NCT07178210. Current status: RECRUITING.

What is the status of NCT07178210?

The current status of NCT07178210 (Robotic-Enabled Microsurgical Intervention for Neurodegenerative Disease) is: RECRUITING.

When did Robotic-Enabled Microsurgical Intervention for Neurodegenerative Disease start?

Robotic-Enabled Microsurgical Intervention for Neurodegenerative Disease started on 2026-03-31.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑